UK-based e-commerce group THG has agreed to sell Claremont Ingredients to Nactarome for £103m in cash. The divestment aligns with THG’s strategy to streamline operations and focus on core strengths. Nactarome, majority-owned by TA Associates, emerged as the successful bidder. The sale marks a significant return on THG’s initial acquisition of Claremont.

THG CEO expressed gratitude to the Claremont team, highlighting the value within THG’s portfolio. Post-disposal, THG expects a reduction in group EBITDA for FY25 and FY26. Claremont’s financials for FY24 show revenue of £14m, EBITDA contributions of £7m, with minimal capital expenditure.

In H1 of 2025, THG anticipates adjusted EBITDA of around £24m, impacted by higher whey pricing. Stable whey prices and global demand allow THG to adjust consumer prices accordingly. Following a refinancing in Q1 2025, THG’s cash and facilities stood at £278m. Net debt before Claremont’s sale was £330m.

THG Nutrition plans for double-digit revenue growth in the second half of 2025 and FY26. Myprotein aims to cap price hikes for the same period, focusing on expanding offline retail presence. A customer-centric strategy backed by a £15m investment is projected to lead to a group adjusted EBITDA of £50m for the second half of the year.

Read more at Yahoo Finance: THG agrees to sell Claremont Ingredients for $137m